Fluorouracil Catabolism in the Combination Treatment of Cyclophosphamide, Methotrexate and Fluorouracil

The CMF‐regimen is amongst the most effective chemotherapeutic approaches in the treatment of breast cancer. It is generally accepted that the efficacy of the combination of the three agents used in the regimen, i.e., cyclophosphamide (CY), methotrexate (MTX) and fluorouracil (FUra), is based on int...

Descripción completa

Detalles Bibliográficos
Autores principales: De Bruijn, Ernst A., Van Der Heyden, Synke A. M., Gheuens, Eric E. O., Maes, Robert A. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 1992
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918667/
https://www.ncbi.nlm.nih.gov/pubmed/1452462
http://dx.doi.org/10.1111/j.1349-7006.1992.tb02728.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918667/
https://www.ncbi.nlm.nih.gov/pubmed/1452462
http://dx.doi.org/10.1111/j.1349-7006.1992.tb02728.x

Ejemplares similares